Back to 
RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P.
SPRY
Showing 8 of 21 quarters
Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in ARS PHARMACEUTICALS INC
Yes. RA Capital Management holds 10,860,977 shares of SPRY (Ars Pharmaceuticals), worth $87M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. RA Capital Management has held SPRY since Q4 2022, across 15 quarterly 13F filings. SPRY is 0.8% of RA Capital Management's reported 13F portfolio.
Current Value
$87M
Current Shares
10.9M
Total Value Change
-$70.5M
Total Shares Change
0
Quarter-by-Quarter History